B-cell epitope prediction for peptide-based vaccine design: Towards a paradigm of biological outcomes for global health

Immunome Research

Volumn 7, Issue 2, 2011, Pages

  Caoili, Salvador Eugenio C ^a  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; PEPTIDE VACCINE;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; B LYMPHOCYTE; CROSS REACTION; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNIZATION; IMMUNOBIOLOGY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; PREDICTION; QUANTITATIVE ANALYSIS; REVIEW; T LYMPHOCYTE;

EID: 84867074310     PISSN: None     EISSN: 17457580     Source Type: Journal    
DOI: None     Document Type: Review

References (181)

1. Petrovsky N, Brusic V: Computational immunology: The coming of age. Immunol Cell Biol 2002, 80(3):248-254. (Pubitemid 34639375)
2. Brusic V, Petrovsky N: Immunoinformatics and its relevance to understanding human immune disease. Expert Rev Clin Immunol 2005, 1:145-157.
3. Chan C, Kepler TB: Computational immunology-from bench to virtual reality. Ann Acad Med Singapore 2007, 36(2):123-127. (Pubitemid 46640264)
4. Mitha F, Lucas TA, Feng F, Kepler TB, Chan C: The Multiscale Systems Immunology project: software for cell-based immunological simulation. Source Code Biol Med 2008, 3:6.
5. Kleinstein SH: Getting started in computational immunology. PLoS Comput Biol 2008, 4(8):e1000128.
6. Tong JC, Ren EC: Immunoinformatics: Current trends and future directions. Drug Discov Today 2009, 14(13-14):684-689.
7. Rapin N, Lund O, Bernaschi M, Castiglione F: Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 2010, 5(4):e9862.
8. Tomar N, De RK: Immunoinformatics: an integrated scenario. Immunology 2010.
9. Yan Q: Immunoinformatics and systems biology methods for personalized medicine. Methods Mol Biol 2010, 662:203-220.
10. De Groot AS, Sbai H, Aubin CS, McMurry J, Martin W: Immunoinformatics: Mining genomes for vaccine components. Immunol Cell Biol 2002, 80(3):255-269. (Pubitemid 34639376)
11. De Groot AS: Immunome-derived vaccines. Expert Opin Biol Ther 2004, 4(6):767-772.
12. De Groot AS, Rappuoli R: Genome-derived vaccines. Expert Rev Vaccines 2004, 3:59-76. (Pubitemid 38202173)
13. Brusic V, August JT, Petrovsky N: Information technologies for vaccine research. Expert Rev Vaccines 2005, 4(3):407-417. (Pubitemid 40978700)
14. Korber B, LaBute M, Yusim K: Immunoinformatics comes of age. PLoS Comput Biol 2006, 2(6):e71.
15. Moriel DG, Scarselli M, Serino L, Mora M, Rappuoli R, Masignani V: Genome-based vaccine development: a short cut for the future. Hum Vaccin 2008, 4(3):184-188.
16. Rinaudo CD, Telford JL, Rappuoli R, Seib KL: Vaccinology in the genome era. J Clin Invest 2009, 119(9):2515-2525.
17. Seib KL, Dougan G, Rappuoli R: The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLoS Genet 2009, 5(10):e1000612.
18. Cassone A, Rappuoli R: Universal vaccines: shifting to one for many. MBio 2010, 1.
19. Sette A, Rappuoli R: Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010, 33(4):530-541.
20. Flower DR, Macdonald IK, Ramakrishnan K, Davies MN, Doytchinova IA: Computer aided selection of candidate vaccine antigens. Immunome Res 2010, 6 Suppl 2:S1.
21. Sollner J, Heinzel A, Summer G, Fechete R, Stipkovits L, Szathmary S, Mayer B: Concept and application of a computational vaccinology workflow. Immunome Res 2010, 6 Suppl 2:S7.
22. Beaglehole R, Bonita R: What is global health? Glob Health Action 2010, 3.
23. Beasley V: 'One toxicology', 'ecosystem health' and 'one health'. Vet Ital 2009, 45:97-110.
24. Rock M, Buntain BJ, Hatfield JM, Hallgrimsson B: Animal-human connections, 'one health,' and the syndemic approach to prevention. Soc Sci Med 2009, 68(6):991-995.
25. Kahn RE, Clouser DF, Richt JA: Emerging Infections: A Tribute to the One Medicine, One Health Concept. Zoonoses Public Health 2009.
26. Osburn B, Scott C, Gibbs P: One world-one medicine-one health: emerging veterinary challenges and opportunities. Rev Sci Tech 2009, 28(2):481-486.
27. Omran AR: The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971, 49(4):509-538.
28. Barrett R, Kuzawa CW, McDade T, Armelagos GJ: Emerging and re-emerging infectious diseases: the third epidemiologic transition. Annu Rev Anthropol 1998, 27:247-271.
29. Strachan DP: Hay fever, hygiene, and household size. BMJ 1989, 299(6710):1259-1260.
30. Kabesch M, Lauener RP: Why Old McDonald had a farm but no allergies: genes, environments, and the hygiene hypothesis. J Leukoc Biol 2004, 75(3):383-387. (Pubitemid 38316366)
31. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA: Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 2006, 3(5):275-284. (Pubitemid 43675024)
32. Garn H, Renz H: Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007, 212(6):441-452. (Pubitemid 46825255)
33. Martinez FD: The coming-of-age of the hygiene hypothesis. Respir Res 2001, 2(3):129-132.
34. Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E: The hygiene hypothesis of atopic disease-an extended version. J Pediatr Gastroenterol Nutr 2004, 38(4):378-388.
35. Romagnani S: The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004, 112(3):352-363.
36. Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J: Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin Exp Allergy 2006, 36(4):402-425.
37. Renz H, Blumer N, Virna S, Sel S, Garn H: The immunological basis of the hygiene hypothesis. Chem Immunol Allergy 2006, 91:30-48. (Pubitemid 43097194)
38. Rook GA: The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders. Trans R Soc Trop Med Hyg 2007, 101(11):1072-1074.
39. Tse K, Horner AA: Allergen tolerance versus the allergic march: the hygiene hypothesis revisited. Curr Allergy Asthma Rep 2008, 8(6):475-483.
40. Rook GA: Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 2009, 126:3-11.
41. Jackson JA, Friberg IM, Little S, Bradley JE: Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? Immunology 2009, 126:18-27.
42. Weinstock JV, Elliott DE: Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 2009, 15:128-133.
43. Sironi M, Clerici M: The hygiene hypothesis: an evolutionary perspective. Microbes Infect 2010, 12(6):421-427.
44. Beddoe R, Costanza R, Farley J, Garza E, Kent J, Kubiszewski I, Martinez L, McCowen T, Murphy K, Myers N, Ogden Z, Stapleton K, Woodward J: Overcoming systemic roadblocks to sustainability: the evolutionary redesign of worldviews, institutions, and technologies. Proc Natl Acad Sci U S A 2009, 106(8):2483-2489.
45. Marshall SJ: Developing countries face double burden of disease. Bull World Health Organ 2004, 82(7):556.
46. Fauci AS: Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell 2006, 124(4):665-670.
47. Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R, Hardell L: The growing incidence of cancer: role of lifestyle and screening detection (Review). Int J Oncol 2007, 30(5):1037-1049.
48. Hans D, Young PR, Fairlie DP: Current status of short synthetic peptides as vaccines. Med Chem 2006, 2(6):627-646. (Pubitemid 44741618)
49. Purcell AW, McCluskey J, Rossjohn J: More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 2007, 6(5):404-414. (Pubitemid 46696551)
50. Gay CG, Zuerner R, Bannantine JP, Lillehoj HS, Zhu JJ, Green R, Pastoret PP: Genomics and vaccine development. Rev Sci Tech 2007, 26:49-67. (Pubitemid 47148812)
51. Van Regenmortel MH: What is a B-cell epitope? Methods Mol Biol 2009, 524:3-20.
52. Ju ST, Nonogaki T, Bernatowicz MS, Matsueda GR: The B cell immune response to an idiotype-inducing peptide epitope can be inhibited by immunodominance of a neighboring epitope. J Immunol 1993, 150(7):2641-2647. (Pubitemid 23127513)
53. Hopp TP, Woods KR: Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 1981, 78(6):3824-3828. (Pubitemid 11060471)
54. Pellequer JL, Westhof E, Van Regenmortel MH: Predicting location of continuous epitopes in proteins from their primary structures. Methods Enzymol 1991, 203:176-201.
55. Blythe MJ, Flower DR: Benchmarking B cell epitope prediction: under-performance of existing methods. Protein Sci 2005, 14:246-248. (Pubitemid 40054138)
56. Jameson BA, Wolf H: The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 1988, 4:181-186. (Pubitemid 18072035)
57. Alix AJ: Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine 1999, 18(3-4):311-314.
58. Odorico M, Pellequer JL: BEPITOPE: predicting the location of continuous epitopes and patterns in proteins. J Mol Recognit 2003, 16:20-22. (Pubitemid 36198956)
59. Van Regenmortel MH, Pellequer JL: Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three-dimensional problem? Pept Res 1994, 7(4):224-228.
60. Kulkarni-Kale U, Bhosle S, Kolaskar AS: CEP: a conformational epitope prediction server. Nucleic Acids Res 2005, 33(Web Server issue):W168-W171.
61. Batori V, Friis EP, Nielsen H, Roggen EL: An in silico method using an epitope motif database for predicting the location of antigenic determinants on proteins in a structural context. J Mol Recognit 2006, 19:21-29. (Pubitemid 43129783)
62. Caoili SE: A structural-energetic basis for B-cell epitope prediction. Protein Pept Lett 2006, 13(7):743-751.
63. Haste Andersen P, Nielsen M, Lund O: Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 2006, 15(11):2558-2567. (Pubitemid 44771693)
64. Sweredoski MJ, Baldi P: PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure. Bioinformatics 2008, 24(12):1459-1460. (Pubitemid 351851001)
65. Ponomarenko J, Bui HH, Li W, Fusseder N, Bourne PE, Sette A, Peters B: ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 2008, 9:514.
66. Rubinstein ND, Mayrose I, Pupko T: A machine-learning approach for predicting B-cell epitopes. Mol Immunol 2009, 46(5):840-847.
67. Caoili SE: Immunization with Peptide-Protein Conjugates: Impact on Benchmarking B-Cell Epitope Prediction for Vaccine Design. Protein Pept Lett 2010, 17(3):386-398.
68. Larsen JE, Lund O, Nielsen M: Improved method for predicting linear B-cell epitopes. Immunome Res 2006, 2:2.
69. Sollner J: Selection and combination of machine learning classifiers for prediction of linear B-cell epitopes on proteins. J Mol Recognit 2006, 19(3):209-214.
70. Sollner J, Mayer B: Machine learning approaches for prediction of linear B-cell epitopes on proteins. J Mol Recognit 2006, 19(3):200-208. (Pubitemid 43874854)
71. Saha S, Raghava GP: Prediction methods for B-cell epitopes. Methods Mol Biol 2007, 409:387-394.
72. Chen J, Liu H, Yang J, Chou KC: Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. Amino Acids 2007, 33(3):423-428. (Pubitemid 47347952)
73. Sollner J, Grohmann R, Rapberger R, Perco P, Lukas A, Mayer B: Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins. Immunome Res 2008, 4:1.
74. El-Manzalawy Y, Dobbs D, Honavar V: Predicting linear B-cell epitopes using string kernels. J Mol Recognit 2008, 21(4):243-255. (Pubitemid 352019054)
75. Huang J, Honda W, Kanehisa M: Predicting B cell epitope residues with network topology based amino acid indices. Genome Inform 2007, 19:40-49.
76. Chang HT, Liu CH, Pai TW: Estimation and extraction of B-cell linear epitopes predicted by mathematical morphology approaches. J Mol Recognit 2008, 21(6):431-441.
77. Sweredoski MJ, Baldi P: COBEpro: a novel system for predicting continuous B-cell epitopes. Protein Eng Des Sel 2009, 22(3):113-120.
78. Zhao L, Li J: Mining for the antibody-antigen interacting associations that predict the B cell epitopes. BMC Struct Biol 2010, 10(Suppl 1):S6.
79. Ansari HR, Raghava GP: Identification of conformational B-cell Epitopes in an antigen from its primary sequence. Immunome Res 2010, 6:6.
80. El-Manzalawy Y, Honavar V: Recent advances in B-cell epitope prediction methods. Immunome Res 2010, 6 Suppl 2:S2.
81. Caoili SE: Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: problems and prospects. J Biomed Biotechnol 2010.
82. Van Regenmortel MH: Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines. J Mol Recognit 2006, 19(3):183-187.
83. Van Regenmortel MH: Synthetic peptide vaccines and the search for neutralization B cell epitopes. Open Vaccine J 2009, 2:33-44.
84. Kanaly CW, Ding D, Heimberger AB, Sampson JH: Clinical applications of a peptide-based vaccine for glioblastoma. Neurosurg Clin N Am 2010, 21:95-109.
85. Nardin E: The past decade in malaria synthetic peptide vaccine clinical trials. Hum Vaccin 2010, 6:27-38.
86. Van Regenmortel MH: Pitfalls of reductionism in the design of peptide-based vaccines. Vaccine 2001, 19(17-19):2369-2374.
87. Van Regenmortel MH: Reductionism and the search for structure-function relationships in antibody molecules. J Mol Recognit 2002, 15(5):240-247.
88. Novotny J, Bajorath J: Computational biochemistry of antibodies and T-cell receptors. Adv Protein Chem 1996, 49:149-260. (Pubitemid 26360377)
89. Caoili SE: Rationalizing the selection of empirical reference data to benchmark B-cell epitope prediction for peptide-based vaccine design [abstract]. Amino Acids 2009, 3 (Suppl 1):S94.
90. Greenbaum JA, Haste Andersen P, Blythe M, Bui HH, Cachau RE, Crowe J, Davies M, Kolaskar AS, Lund O, Morrison S, Mumey B, Ofran Y, Pellequer JL, Pinilla C, Ponomarenko JV, Raghava GP, van Regenmortel MH, Roggen EL, Sette A, Schlessinger A, Sollner J, Zand M, Peters B: Towards a con-sensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J Mol Recognit 2007, 20(2):75-82. (Pubitemid 46761248)
91. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, Bui HH, Buus S, Frankild S, Greenbaum J, Lund O, Lundegaard C, Nielsen M, Ponomarenko J, Sette A, Zhu Z, Peters B: Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 2008, 36(Web Server issue):W513-W518.
92. Vita R, Peters B, Sette A: The curation guidelines of the immune epitope database and analysis resource. Cytometry A 2008, 73(11):1066-1070.
93. Partidos CD: Peptide mimotopes as candidate vaccines. Curr Opin Mol Ther 2000, 2:74-79.
94. Deroo S, Muller CP: Antigenic and immunogenic phage displayed mimotopes as substitute antigens: applications and limitations. Comb Chem High Throughput Screen 2001, 4:75-110. (Pubitemid 32405670)
95. Partidos CD, Steward MW: Mimotopes of viral antigens and biologically important molecules as candidate vaccines and potential immunotherapeutics. Comb Chem High Throughput Screen 2002, 5:15-27. (Pubitemid 34292651)
96. Schmidt MA, Raupach B, Szulczynski M, Marzillier J: Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit. Infect Immun 1991, 59(4):1402-1408.
97. Simon PL, Kumar V, Lillquist JS, Bhatnagar P, Einstein R, Lee J, Porter T, Green D, Sathe G, Young PR: Mapping of neutralizing epitopes and the receptor binding site of human interleukin 1 beta. J Biol Chem 1993, 268(13):9771-9779. (Pubitemid 23146039)
98. Gechtman Z, Belleli A, Lechpammer S, Shaltiel S: The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies. Biochem J 1997, 325(Pt 2):339-349.
99. Swets JA: Measuring the accuracy of diagnostic systems. Science 1988, 240(4857):1285-1293.
100. Lund O, Nielsen M, Lundegaard C, Kesmir C, Brunak S: Immunological Bioinformatics. Cambridge: MIT Press, 1st edition 2005.
101. Fedorov V, Mannino F, Zhang R: Consequences of dichotomization. Pharm Stat 2009, 8:50-61.
102. Verdier F: Non-clinical vaccine safety assessment. Toxicology 2002, 174:37-43.
103. Descotes J, Ravel G, Ruat C: Vaccines: predicting the risk of allergy and autoimmunity. Toxicology 2002, 174:45-51. (Pubitemid 34327826)
104. Van Regenmortel MH: Biological complexity emerges from the ashes of genetic reductionism. J Mol Recognit 2004, 17(3):145-148.
105. Claverie JM: From bioinformatics to computational biology. Genome Res 2000, 10(9):1277-1279.
106. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, Kennedy K, Wu H, Bennouna S, Oluoch H, Miller J, Vencio RZ, Mulligan M, Aderem A, Ahmed R, Pulendran B: Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10:116-125.
107. Janin J, Rodier F: Protein-protein interaction at crystal contacts. Proteins 1995, 23(4):580-587. (Pubitemid 26009521)
108. Bahadur RP, Chakrabarti P, Rodier F, Janin J: A dissection of specific and non-specific protein-protein interfaces. J Mol Biol 2004, 336(4):943-955. (Pubitemid 38201541)
109. Daforn TR: So how do you know you have a macromolecular complex? Acta Crystallogr D Biol Crystallogr 2007, 63(Pt 1):17-25.
110. Kobe B, Guncar G, Buchholz R, Huber T, Maco B, Cowieson N, Martin JL, Marfori M, Forwood JK: Crystallography and protein-protein interactions: biological interfaces and crystal contacts. Biochem Soc Trans 2008, 36(Pt 6):1438-1441.
111. Mozzarelli A, Rossi GL: Protein function in the crystal. Annu Rev Biophys Biomol Struct 1996, 25:343-365. (Pubitemid 26197503)
112. Hassell AM, An G, Bledsoe RK, Bynum JM, r d Carter HL, Deng SJ, Gampe RT, Grisard TE, Madauss KP, Nolte RT, Rocque WJ, Wang L, Weaver KL, Williams SP, Wisely GB, Xu R, Shewchuk LM: Crystallization of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 2007, 63(Pt 1):72-79.
113. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradovic Z: Intrinsic disorder and protein function. Biochemistry 2002, 41(21):6573-6582. (Pubitemid 34547347)
114. Dunker AK, Oldfield CJ, Meng J, Romero P, Yang JY, Chen JW, Vacic V, Obradovic Z, Uversky VN: The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 2008, 9(Suppl 2):S1.
115. Nelson S, Jost CA, Xu Q, Ess J, Martin JE, Oliphant T, Whitehead SS, Durbin AP, Graham BS, Diamond MS, Pierson TC: Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog 2008, 4(5):e1000060.
116. Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, Chen BR, Nelson CA, Kostyuchenko VA, Holdaway HA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG, Fremont DH: Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J 2009, 28(20):3269-3276.
117. Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, Fremont DH, Diamond MS: The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 2007, 1(2):135-145. (Pubitemid 46554914)
118. Pierson TC, Fremont DH, Kuhn RJ, Diamond MS: Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 2008, 4(3):229-238.
119. Pierson TC, Diamond MS: Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med 2008, 10:e12.
120. Diamond MS, Pierson TC, Fremont DH: The structural immunology of antibody protection against West Nile virus. Immunol Rev 2008, 225:212-225.
121. Mehlhop E, Ansarah-Sobrinho C, Johnson S, Engle M, Fremont DH, Pierson TC, Diamond MS: Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2007, 2(6):417-426. (Pubitemid 350215325)
122. Mehlhop E, Nelson S, Jost CA, Gorlatov S, Johnson S, Fremont DH, Diamond MS, Pierson TC: Complement protein C1q reduces the stoichiometric threshold for antibody mediated neutralization of West Nile virus. Cell Host Microbe 2009, 6(4):381-391.
123. Fuchs A, Lin TY, Beasley DW, Stover CM, Schwaeble WJ, Pierson TC, Diamond MS: Direct complement restriction of flavivirus infection requires glycan recognition by mannose binding lectin. Cell Host Microbe 2010, 8(2):186-195.
124. Peiris JS, Gordon S, Unkeless JC, Porterfield JS: Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature 1981, 289(5794):189-191. (Pubitemid 11076201)
125. Girn J, Kavoosi M, Chantler J: Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J Gen Virol 2002, 83(Pt 2):351-358. (Pubitemid 34134243)
126. Tirado SM, Yoon KJ: Antibody-dependent enhancement of virus infection and disease. Viral Immunol 2003, 16:69-86. (Pubitemid 36427741)
127. Takada A, Kawaoka Y: Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 2003, 13(6):387-398. (Pubitemid 37413260)
128. Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ: Immunoglobulin G antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol 2006, 80(17):8530-8540. (Pubitemid 44384865)
129. Takeda A, Ennis FA: FcR-mediated enhancement of HIV-1 infection by antibody. AIDS Res Hum Retroviruses 1990, 6(8):999-1004. (Pubitemid 20300060)
130. Jiang SB, Lin K, Neurath AR: Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41. J Exp Med 1991, 174(6):1557-1563.
131. Beck Z, Prohaszka Z, Fust G: Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development. Vaccine 2008, 26(24):3078-3085.
132. Stoiber H: Complement, Fc receptors and antibodies: a Trojan horse in HIV infection? Curr Opin HIV AIDS 2009, 4(5):394-399.
133. Mahalingam S, Lidbury BA: Antibody-dependent enhancement of infection: bacteria do it too. Trends Immunol 2003, 24(9):465-467. (Pubitemid 37088145)
134. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM: Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 2010, 10(10):712-722.
135. Mohamed N, Li J, Ferreira CS, Little SF, Friedlander AM, Spitalny GL, Casey LS: Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages. Infect Immun 2004, 72(6):3276-3283. (Pubitemid 38697749)
136. He X, Sun X, Wang J, Wang X, Zhang Q, Tzipori S, Feng H: Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A. Infect Immun 2009, 77(6):2294-2303.
137. Yoong P, Pier GB: Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci U S A 2010, 107(5):2241-2246.
138. Thomas S, Redfern JB, Lidbury BA, Mahalingam S: Antibody-dependent enhancement and vaccine development. Expert Rev Vaccines 2006, 5(4):409-412. (Pubitemid 44627873)
139. Mummert ME, Voss EW Jr: Transition-state theory and secondary forces in antigen-antibody complexes. Biochemistry 1996, 35(25):8187-8192. (Pubitemid 26234919)
140. van Oss CJ: Kinetics and energetics of specific intermolecular interactions. J Mol Recognit 1997, 10(5):203-216.
141. Murphy KP, Freire E: Thermodynamics of structural stability and cooperative folding behavior in proteins. Adv Protein Chem 1992, 43:313-361.
142. Murphy KP: Predicting binding energetics from structure: looking beyond ΔG°. Med Res Rev 1999, 19(4):333-339. (Pubitemid 29319236)
143. Edgcomb SP, Murphy KP: Structural energetics of protein folding and binding. Curr Opin Biotechnol 2000, 11:62-66. (Pubitemid 30099040)
144. Nakra P, Manivel V, Vishwakarma RA, Rao KV: B cell responses to a peptide epitope. X. Epitope selection in a primary response is thermodynamically regulated. J Immunol 2000, 164(11):5615-5625. (Pubitemid 30389801)
145. Nayak BP, Tuteja R, Manivel V, Roy RP, Vishwakarma RA, Rao KV: B cell responses to a peptide epitope. V. Kinetic regulation of repertoire discrimination and antibody optimization for epitope. J Immunol 1998, 161(7):3510-3519.
146. Agarwal A, Rao KV: B cell responses to a peptide epitope: III. Differential T helper cell thresholds in recruitment of B cell fine specificities. J Immunol 1997, 159(3):1077-1085. (Pubitemid 127484082)
147. Rao KV: Selection in a T-dependent primary humoral response: new insights from polypeptide models. APMIS 1999, 107(9):807-818.
148. Anderson SM, Khalil A, Uduman M, Hershberg U, Louzoun Y, Haberman AM, Kleinstein SH, Shlomchik MJ: Taking advantage: high-affinity B cells in the germinal center have lower death rates, but similar rates of division, compared to low-affinity cells. J Immunol 2009, 183(11):7314-7325.
149. Kesmir C, Boer RJD: A spatial model of germinal center reactions: cellular adhesion based sorting of B cells results in efficient affinity maturation. J Theor Biol 2003, 222:9-22. (Pubitemid 36434076)
150. Dybwad A, Bogen B, Natvig JB, Forre O, Sioud M: Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera. Clin Exp Immunol 1995, 102(2):438-442.
151. Sioud M, Forre O, Dybwad A: Selection of ligands for polyclonal antibodies from random peptide libraries: potential identification of (auto)antigens that may trigger B and T cell responses in autoimmune diseases. Clin Immunol Immunopathol 1996, 79(2):105-114. (Pubitemid 26150335)
152. Hileman RE, Silvanovich A, Goodman RE, Rice EA, Holleschak G, Ashwood JD, Hefle SL: Bioinformatic methods for allergenicity assessment using a comprehensive allergen database. Int Arch Allergy Immunol 2002, 128(4):280-291.
153. Ivanciuc O, Schein CH, Braun W: SDAP: database and computational tools for allergenic proteins. Nucleic Acids Res 2003, 31:359-362. (Pubitemid 36150403)
154. Brusic V, Millot M, Petrovsky N, Gendel SM, Gigonzac O, Stelman SJ: Allergen databases. Allergy 2003, 58(11):1093-1100. (Pubitemid 37372293)
155. Francis T Jr: On the doctrine of original antigenic sin. Proc Am Philos Soc 1960, 104(6):572-578.
156. Muller S: Avoiding deceptive imprinting of the immune response to HIV1 infection in vaccine development. Int Rev Immunol 2004, 23(5-6):423-436.
157. Morens DM, Burke DS, Halstead SB: The wages of original antigenic sin. Emerg Infect Dis 2010, 16(6):1023-1024.
158. Davies JM: Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 1997, 75(2):113-126.
159. Hebeis BJ, Klenovsek K, Rohwer P, Ritter U, Schneider A, Mach M, Winkler TH: Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med 2004,199(4):593-602. (Pubitemid 38233842)
160. Kohler H, Muller S, Nara PL: Deceptive imprinting in the immune r sponse against HIV-1. Immunol Today 1994, 15(10):475-478. (Pubitemid 24316013)
161. Nara PL, Garrity R: Deceptive imprinting: a cosmopolitan strategy for complicating vaccination. Vaccine 1998, 16(19):1780-1787. (Pubitemid 28476355)
162. Nara PL: Deceptive imprinting: insights into mechanisms of immune evasion and vaccine development. Adv Vet Med 1999, 41:115-134.
163. Neurath AR, Strick N, Lee ES: B cell epitope mapping of human immune deficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides. J Gen Virol 1990, 71(Pt 1):85-95. (Pubitemid 20046013)
164. Novotny LA, Bakaletz LO: The fourth surface-exposed region of the outer membrane protein P5-homologous adhesin of nontypable Haemophilus influenzae is an immnodominant but nonprotective decoying epitope. J Immunol 2003, 171(4):1978-1983. (Pubitemid 36966481)
165. Graille M, Stura EA, Bossus M, Muller BH, Letourneur O, Battail-Poirot N, Sibai G, Gauthier M, Rolland D, Du MHL, Ducancel F: Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response. J Mol Biol 2005, 354(2):447-458. (Pubitemid 41581679)
166. Lin G, Nara PL: Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein. Curr HIV Res 2007, 5(6):514-541. (Pubitemid 351210987)
167. Tobin GJ, Trujillo JD, Bushnell RV, Lin G, Chaudhuri AR, Long J, Barrera J, Pena L, Grubman MJ, Nara PL: Deceptive imprinting and immune refocusing in vaccine design. Vaccine 2008, 26(49):6189-6199.
168. Bull JJ, Meyers LA, Lachmann M: Quasispecies made simple. PLoS Co put Biol 2005, 1(6):e61.
169. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
170. Matzinger P: The danger model: a renewed sense of self. Science 2002, 296(5566):301-305.
171. Pirofski LA, Casadevall A: The damage-response framework of microbial pathogenesis and infectious diseases. Adv Exp Med Biol 2008, 635:135-146.
172. Macklin R: Standard of care: an evolution in ethical thinking. Lancet 2008, 372(9635):284-285.
173. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E: Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 2010, 6(2):e1000790.
174. Van Regenmortel MH: Transcending the structuralist paradigm in Imunology-affinity and biological activity rather than purely structural considerations should guide the design of synthetic peptide epitopes. Biomed Pept Proteins Nucleic Acids 1995, 1(3):109 116.
175. Van Regenmortel MHV: Mapping epitope structure and activity: from one-dimensional prediction to four-dimensional description of antigenic specificity. Methods 1996, (3):465-472.
176. Nudelman G, Louzoun Y: The role of lipid rafts in cell surface BCR antigen binding dynamics. Conf Proc IEEE Eng Med Biol Soc 2004, 1:667-670. (Pubitemid 40043933)
177. Nudelman G, Louzoun Y: Cell surface dynamics: the balance between diffusion, aggregation and endocytosis. Syst Biol (Stevenage) 2006, 153:34-42. (Pubitemid 43149951)
178. Nudelman G, Weigert M, Louzoun Y: In-silico cell surface modeling reveals mechanism for initial steps of B-cell receptor signal transduction. Mol Immunol 2009, 46(15):3141 3150.
179. Casadevall A, Pirofski LA: Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. J Exp Med 2003, 197(11):1401-1404. (Pubitemid 36682539)
180. Schotsaert M, Ibanez LI, Fiers W, Saelens X: Controlling influenza by cytotoxic T-cells: calling for help from destroyers. J Biomed Biotechnol 2010, 2010:863985.
181. Long KZ, Nanthakumar N: Energetic and nutritional regulation of the adaptive immune response and trade-offs in ecological immunology. Am J Hum Biol 2004, 16(5):499-507. (Pubitemid 39199844)